Joining forces to develop individualized antisense oligonucleotides for patients with brain or eye diseases: the example of the Dutch Center for RNA Therapeutics
- DOI
- 10.1177/26330040241273465
- Published
- 2024-01
- Container
- Therapeutic Advances in Rare Disease
- Publisher
- SAGE Publications
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1177/26330040241273465,
title = {Joining forces to develop individualized antisense oligonucleotides for patients with brain or eye diseases: the example of the Dutch Center for RNA Therapeutics},
author = {Annemieke Aartsma-Rus and Rob W.J. Collin and Ype Elgersma and Marlen C. Lauffer and Willeke van Roon-Mom},
year = {2024},
journal = {Therapeutic Advances in Rare Disease},
doi = {10.1177/26330040241273465},
url = {https://doi.org/10.1177/26330040241273465}
}RIS
TY - JOUR TI - Joining forces to develop individualized antisense oligonucleotides for patients with brain or eye diseases: the example of the Dutch Center for RNA Therapeutics AU - Annemieke Aartsma-Rus AU - Rob W.J. Collin AU - Ype Elgersma AU - Marlen C. Lauffer AU - Willeke van Roon-Mom PY - 2024 JO - Therapeutic Advances in Rare Disease DO - 10.1177/26330040241273465 UR - https://doi.org/10.1177/26330040241273465 ER -
APA
Aartsma-Rus, A., Collin, R. W., Elgersma, Y., Lauffer, M. C., & Roon-Mom, W. V. (2024). Joining forces to develop individualized antisense oligonucleotides for patients with brain or eye diseases: the example of the Dutch Center for RNA Therapeutics. Therapeutic Advances in Rare Disease. https://doi.org/10.1177/26330040241273465
Source records
- crossref · retrieved 2026-09-25T23:01:41.550Z